Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022)
Zai Lab's (ZLAB) quarterly Current Deferred Revenue came in at $26.9 million in Q1 2022, up 61.47% year-on-year from $16.7 million in Q1 2021, and down 2.15% quarter-over-quarter from $27.5 million in Q4 2021.
Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022) Analysis & Trends
Zai Lab has disclosed Current Deferred Revenue across 6 years of filings, most recently posting $26.9 million for Q1 2022.
- Current Deferred Revenue for Q1 2022 came in at $26.9 million, up 61.47% year-over-year; the trailing twelve-month figure through Mar 2022 was $26.9 million (up 61.47% YoY), and the FY2021 annual result was $27.5 million, up 63.04% from the prior year.
- Current Deferred Revenue came in at $26.9 million for Q1 2022 at Zai Lab, down from $27.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $27.5 million in Q4 2021 to a low of $2.1 million in Q4 2018.
- The 5-year median for Current Deferred Revenue is $17.2 million (2020), against an average of $16.0 million.
- Across the five-year window, Current Deferred Revenue declined 13.79% in 2018 and soared 485.14% in 2020, its largest moves.
- Zai Lab's Current Deferred Revenue stood at $2.1 million in 2018, then jumped by 39.58% to $2.9 million in 2019, then jumped by 485.14% to $16.9 million in 2020, then surged by 63.04% to $27.5 million in 2021, then slipped by 2.15% to $26.9 million in 2022.
- The last three Current Deferred Revenue figures came in at $26.9 million (Q1 2022), $27.5 million (Q4 2021), and $17.5 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 26.90 Mn |
| Dec 31, 2021 | 27.49 Mn |
| Sep 30, 2021 | 17.49 Mn |
| Jun 30, 2021 | 17.63 Mn |
| Mar 31, 2021 | 16.66 Mn |
| Dec 31, 2020 | 16.86 Mn |
| Dec 31, 2019 | 2.88 Mn |
| Dec 31, 2018 | 2.06 Mn |
| Dec 31, 2017 | 2.39 Mn |